Mizuho raises Xcel Energy stock price target to $80 ahead of fire trial

Mizuho raised its price target on Xcel Energy (XEL) to $80, maintaining an Outperform rating, citing a high bar for a jury to find XEL negligent in the upcoming Marshall fire trial given Colorado's legal framework and the company's projected 6-8% EPS CAGR. This positive outlook is supported by XEL's strong Q2 2025 financial results, which exceeded EPS and revenue forecasts, and a recent upgrade to Outperform by BMO Capital, alongside a new $4 billion equity distribution agreement and approved interim rates in Minnesota.

Analysis

Xcel Energy (XEL) is receiving positive analyst attention, with Mizuho raising its price target to $80.00 and BMO Capital upgrading the stock to Outperform. This sentiment is supported by strong second-quarter 2025 financial results, where EPS of $0.75 surpassed the $0.66 forecast and revenue of $3.29 billion exceeded the $3.23 billion estimate. A key overhang, the 2021 Marshall fire litigation, is viewed by Mizuho as having a 'high bar' for a plaintiff ruling due to Colorado's specific legal framework and multiple causal theories, potentially mitigating a major risk factor. The company's valuation appears reasonable, trading at a group-average P/E multiple of 20.26x while offering a projected 6-8% EPS CAGR and a stable Baa1/BBB balance sheet. The stock's low volatility, indicated by a beta of 0.36, adds to its defensive appeal. However, investors should note two moderating factors: a new $4 billion equity distribution agreement introduces potential share dilution, and the recent Minnesota rate case resulted in an interim rate approval of $192 million, significantly less than the $491 million originally requested.

Key Decisions for Investors

• Given the strong Q2 earnings beat, positive analyst revisions, and a projected 6-8% EPS growth, investors may view the stock favorably, particularly as its valuation is considered in-line with peers.
• It is critical to monitor the upcoming Marshall fire trial in Colorado, as any outcome suggesting higher-than-expected liability for Xcel could serve as a significant negative catalyst, challenging the current bullish thesis.
• Investors should factor in the potential for future share dilution from the $4 billion equity distribution agreement and closely watch regulatory rate case outcomes, as they directly impact the company's ability to achieve its revenue and growth targets.